Warning! You won't be able to use the quotation basket until you enable cookies in your Web browser.
Warning! Your Web browser is no longer supported. Please upgrade to a modern browser.

Evolution of Biomarker Validation

PACE credits are no longer available for webinars more than 6 months old.


Most recently, an international team of experts from the International Society for Immunohistochemistry and Molecular Morphology (ISIMM) as well as the International Network for Quality in Pathology (IQN Path) developed new concepts and a new framework for biomarker validation in immunohistochemistry (IHC). Validation is ‘‘confirmation, through the provision of objective evidence, that requirements for a specific intended use or application have been fulfilled’’ (ISO 9000).“Intended use” or “intended application” are synonymous with “purpose” meaning that validation will result in a test that is fit-for-purpose. Provision of “objective evidence” is fulfilled by collecting evidence that relevant test performance characteristics have been identified and assessed. Validation provides a “high degree of assurance” that these needs will be met. This presentation will explore how these three components of validation (intended use, objective evidence, and high degree of assurance) can be incorporated into the validation of biomarkers for in-situ cell-based assays such as IHC.

Learning Objectives:

  1. Overview of terminology and definitions relevant to biomarker validation for in situ, cell-based assays.
  2. Describe components and processes for IHC biomarker validation.
  3. Describe tools required for biomarker validation.

Leica Biosystems webinars, training presentations and related materials provide general information regarding particular subjects and are not intended to be, and should not be construed as medical, regulatory or legal advice. The views and opinions expressed are the personal views and opinions of the speaker(s)/author(s) and do not necessarily represent or reflect the views or opinions of Leica Biosystems, its employees or agents.

For the use of any product, the product information guides, inserts and operation manuals of the various products and devices should be consulted. Leica Biosystems and the editors disclaim any liability arising directly or indirectly from the use of devices, techniques or procedures described in these materials.

Copyright © 2016 by Leica Biosystems Richmond Inc. All rights reserved.LEICA and the Leica Logo are registered trademarks of Leica Microsystems IR GmbH.